aTyr Pharma Inc.

NASDAQ: ATYR · Real-Time Price · USD
4.90
-0.09 (-1.80%)
At close: Aug 15, 2025, 3:59 PM
4.93
0.61%
After-hours: Aug 15, 2025, 07:48 PM EDT

aTyr Pharma Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-66.64M -63.41M -64.02M -63.82M -57.9M -53.93M -50.39M -43.15M -45.05M -45.14M -45.34M -46.38M -40.8M -38.77M -33.77M -30.15M -29.08M -25.14M
Depreciation & Amortization
1.16M 1.15M 1.54M 1.95M 2.55M 2.76M 2.74M 3.03M 2.45M 2.15M 1.7M 1.32M 1.23M 1.3M 1.3M 1.23M 1.2M 1.21M
Stock-Based Compensation
4M 3.43M 2.99M 2.88M 2.79M 2.72M 2.6M 2.55M 2.5M 1.84M 1.22M 615K n/a 398K 758K 1.1M 1.42M 1.4M
Other Working Capital
3.34M 3.83M -5.98M -6.09M -6.37M -6.7M 2.7M 8.12M 4.84M 4.98M 4.35M -2.02M -3.06M -583K -2.86M -1.83M 912K -1.02M
Other Non-Cash Items
-2.15M -2.42M -2.71M -3.04M -3.41M -2.45M -8.76M 4.22M 4.94M 3.11M 11.16M 471K 3.42M 5.08M 4.2M 2.86M 331K 399K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
8.02M -903K -6.92M -5.02M -7.49M -2.99M 15.01M 7.37M 6.08M 8.4M -833K 2.8M -1.62M -2.04M -2.59M -3.22M 1.65M -1.05M
Operating Cash Flow
-55.6M -62.16M -69.12M -67.05M -63.45M -55.01M -33.22M -32.53M -35.25M -32.36M -41.89M -39.6M -38.79M -37.37M -33.08M -30.39M -24.48M -23.19M
Capital Expenditures
-49K -48K -65K -57K -599K -2.99M -4.21M -5.32M -5.19M -2.84M -1.64M -540K -175K -218K -192K -179K -130K -53K
Cash Acquisitions
7K 7K 7K n/a n/a 15K 15K 15K 25K 10K 179K 229K 219K 219K 50K n/a n/a n/a
Purchase of Investments
-70.24M -70.87M -69.1M -52.7M -78.4M -82.09M -106.98M -122.31M -99.64M -88.34M -42.12M -74.82M -97.66M -100.83M -126.51M -69.71M -43.08M -43.66M
Sales Maturities Of Investments
80.04M 85.08M 86.39M 93.89M 106.57M 101.75M 91.05M 91.66M 85.13M 85.63M 90.83M 71.03M 58.01M 47.28M 35.08M 30.87M 20.77M 15.8M
Other Investing Acitivies
981K n/a n/a n/a n/a -1.76M -38.69M -35.57M -14.49M -12.73M 24.19M 21.07M n/a n/a n/a 6K 15K 15K
Investing Cash Flow
10.74M 14.17M 17.23M 41.14M 27.57M 16.69M -20.13M -35.95M -19.68M -5.55M 47.24M -4.1M -39.6M -53.55M -91.57M -39.02M -22.43M -27.9M
Debt Repayment
-517K -507K -497K -484K -467K -449K -394K -279K -171K -66K n/a n/a n/a n/a n/a -3.08M -5.08M -7.08M
Common Stock Repurchased
79K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
61K 100K 100K 79K 79K 105K 105K 983K 983K 923K 924K 15K 73K 74K 73K 68K 10K 10K
Financial Cash Flow
55.26M 50.76M 39.86M 27.06M 29.85M 24.46M 66.23M 61.11M 61.45M 53.47M 5.45M 4.56M 85.42M 86.65M 110.03M 111M 27.46M 24.22M
Net Cash Flow
10.4M 2.77M -11.75M 1.38M -5.83M -13.88M 12.56M -8.57M 3.83M 12.37M 7.64M -41.38M 6.29M -4.26M -14.62M 41.59M -19.44M -26.87M
Free Cash Flow
-55.65M -62.21M -69.18M -67.11M -64.05M -58M -37.44M -37.84M -40.44M -35.2M -43.53M -40.14M -38.97M -37.59M -33.27M -30.57M -24.61M -23.24M